Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer
Forkhead box protein A1 (FOXA1) is essential for androgen-dependent prostate cancer
(PCa) growth. However, how FOXA1 levels are regulated remains elusive and its …
(PCa) growth. However, how FOXA1 levels are regulated remains elusive and its …
Lecture notes on ridge regression
WN van Wieringen - arXiv preprint arXiv:1509.09169, 2015 - arxiv.org
The linear regression model cannot be fitted to high-dimensional data, as the high-
dimensionality brings about empirical non-identifiability. Penalized regression overcomes …
dimensionality brings about empirical non-identifiability. Penalized regression overcomes …
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours
Molecular heterogeneity characterizes tumours' evolution and adaptation and, because of its
dynamics and continuous changes under external pressure, it is one of the major causes of …
dynamics and continuous changes under external pressure, it is one of the major causes of …
[HTML][HTML] The importance of DNA methylation in prostate cancer development
After briefly reviewing the nature of DNA methylation, its general role in cancer and the tools
available to interrogate it, we consider the literature surrounding DNA methylation as …
available to interrogate it, we consider the literature surrounding DNA methylation as …
Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy
Background Prostate cancer (PCa) is a leading reason of death in men and the most
diagnosed malignancies in the western countries at the present time. After radical …
diagnosed malignancies in the western countries at the present time. After radical …
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
A Ali, B Mekhaeil, OD Biziotis, EE Tsakiridis… - Communications …, 2023 - nature.com
Radiotherapy is a non-invasive standard treatment for prostate cancer (PC). However, PC
develops radio-resistance, highlighting a need for agents to improve radiotherapy response …
develops radio-resistance, highlighting a need for agents to improve radiotherapy response …
Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancer
XW Zhang, JY Li, L Li, WQ Hu, Y Tao, WY Gao… - Cell Death & …, 2023 - nature.com
The widespread application of antiandrogen therapies has aroused a significant increase in
the incidence of NEPC, a lethal form of the disease lacking efficient clinical treatments. Here …
the incidence of NEPC, a lethal form of the disease lacking efficient clinical treatments. Here …
Genomic amplifications and distal 6q loss: novel markers for poor survival in high-risk neuroblastoma patients
P Depuydt, V Boeva, TD Hocking… - JNCI: Journal of the …, 2018 - academic.oup.com
Background Neuroblastoma is characterized by substantial clinical heterogeneity. Despite
intensive treatment, the survival rates of high-risk neuroblastoma patients are still …
intensive treatment, the survival rates of high-risk neuroblastoma patients are still …
Gene regulatory mechanisms underpinning prostate cancer susceptibility
T Whitington, P Gao, W Song, H Ross-Adams… - Nature …, 2016 - nature.com
Molecular characterization of genome-wide association study (GWAS) loci can uncover key
genes and biological mechanisms underpinning complex traits and diseases. Here we …
genes and biological mechanisms underpinning complex traits and diseases. Here we …
Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
Immunotherapy is poised to become an increasingly utilized therapy in the treatment of
cancer. However, several abnormalities in the tumor microenvironment (TME) that can …
cancer. However, several abnormalities in the tumor microenvironment (TME) that can …